Zoetis Inc (ZTS) Stake Lessened by Pensionfund Sabic

Pensionfund Sabic decreased its position in Zoetis Inc (NYSE:ZTS) by 14.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 21,200 shares of the company’s stock after selling 3,500 shares during the period. Pensionfund Sabic’s holdings in Zoetis were worth $2,134,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Berman Capital Advisors LLC bought a new position in Zoetis in the 4th quarter worth $26,000. Athena Capital Advisors LLC bought a new stake in Zoetis in the fourth quarter valued at about $29,000. Resources Investment Advisors Inc. bought a new stake in Zoetis in the fourth quarter valued at about $31,000. Lavaca Capital LLC bought a new stake in Zoetis in the fourth quarter valued at about $32,000. Finally, Acima Private Wealth LLC bought a new stake in Zoetis in the fourth quarter valued at about $34,000. 90.84% of the stock is owned by hedge funds and other institutional investors.

In other Zoetis news, insider Kristin C. Peck sold 11,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $86.79, for a total value of $998,085.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Clinton A. Jr. Lewis sold 6,125 shares of the company’s stock in a transaction that occurred on Thursday, February 14th. The shares were sold at an average price of $91.96, for a total transaction of $563,255.00. Following the completion of the sale, the insider now directly owns 45,512 shares of the company’s stock, valued at approximately $4,185,283.52. The disclosure for this sale can be found here. Insiders sold 410,333 shares of company stock valued at $38,674,547 in the last ninety days. Insiders own 0.29% of the company’s stock.

A number of analysts recently weighed in on ZTS shares. Zacks Investment Research cut shares of Zoetis from a “hold” rating to a “sell” rating in a research note on Monday, February 4th. UBS Group initiated coverage on shares of Zoetis in a research report on Wednesday, January 23rd. They issued a “neutral” rating and a $86.00 price target on the stock. Stifel Nicolaus upgraded shares of Zoetis from a “hold” rating to a “buy” rating and boosted their price target for the company from $97.00 to $110.00 in a research report on Monday, March 4th. SunTrust Banks initiated coverage on shares of Zoetis in a research report on Tuesday, March 19th. They issued a “hold” rating and a $100.00 price target on the stock. Finally, BMO Capital Markets boosted their price target on shares of Zoetis from $93.00 to $101.00 and gave the company a “market perform” rating in a research report on Monday, February 25th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $101.77.

Shares of ZTS stock traded up $1.85 during trading hours on Tuesday, reaching $101.97. 2,532,291 shares of the company were exchanged, compared to its average volume of 2,331,877. The company has a current ratio of 3.60, a quick ratio of 2.46 and a debt-to-equity ratio of 2.95. The firm has a market capitalization of $47.46 billion, a price-to-earnings ratio of 32.58, a PEG ratio of 1.80 and a beta of 0.93. Zoetis Inc has a fifty-two week low of $77.00 and a fifty-two week high of $103.33.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, February 14th. The company reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.77 by $0.02. The business had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.53 billion. Zoetis had a net margin of 24.51% and a return on equity of 73.85%. Zoetis’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.69 earnings per share. On average, equities research analysts forecast that Zoetis Inc will post 3.46 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Shareholders of record on Thursday, April 18th will be paid a $0.164 dividend. This represents a $0.66 annualized dividend and a yield of 0.64%. The ex-dividend date is Wednesday, April 17th. Zoetis’s payout ratio is presently 21.09%.

COPYRIGHT VIOLATION NOTICE: “Zoetis Inc (ZTS) Stake Lessened by Pensionfund Sabic” was first reported by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.baseballdailydigest.com/news/2019/04/24/pensionfund-sabic-has-2-13-million-stake-in-zoetis-inc-zts.html.

Zoetis Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

See Also: What are municipal bonds?

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.